Performance analysis of Sarepta Therapeutics (SRPT)
Annual Return
Over the past 3 years, SRPT has had an average annual return of -45.92%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, SRPT has had an average annual return of -24.64%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, SRPT has had an average annual return of -3.45%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Nov 1, 1999, SRPT has had an average annual return of -1.52%, underperforming the benchmark SPY, which returned +8.46% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.80% | -82.30% | +26.09% | -25.58% | +43.90% | -47.18% | +32.12% | +18.24% | +96.14% | +102.84% | -28.90% | +166.64% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -28.97% | -21.05% | +477.12% | -64.86% | +45.19% | +121.86% | -53.32% | -55.66% | -7.83% | +46.80% | -42.26% | -18.60% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -54.21% | +129.89% | -12.65% | +28.89% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.48% | -17.60% | +29.83% | -4.05% | -14.42% | +0.57% | -6.35% | -21.80% | |||||
| 2025 | -6.47% | -6.13% | -40.22% | -2.23% | -39.74% | -54.52% | -3.97% | +10.84% | +5.87% | +24.61% | -11.12% | +0.84% | -82.30% |
| 2024 | +23.39% | +7.49% | +1.22% | -2.16% | +2.53% | +21.67% | -9.98% | -4.54% | -8.02% | +0.89% | +5.82% | -8.81% | +26.09% |
| 2023 | -3.56% | -2.27% | +12.85% | -10.93% | +0.68% | -7.35% | -5.35% | +11.64% | +0.17% | -44.47% | +20.76% | +18.64% | -25.58% |
| 2022 | -20.52% | +7.04% | +1.97% | -7.42% | +0.69% | +2.94% | +24% | +17.67% | +1.06% | +3.15% | +7.71% | +5.51% | +43.90% |
| 2021 | -47.56% | -2.62% | -14.39% | -4.95% | +6.79% | +2.76% | -12.81% | +15.25% | +18.38% | -14.44% | +2.12% | +11.43% | -47.18% |
| 2020 | -10.14% | -1.29% | -14.54% | +20.51% | +29.17% | +5.30% | -4.25% | -4.62% | -4.09% | -3.22% | +3.64% | +21.04% | +32.12% |
| 2019 | +28.02% | +3.24% | -17.37% | -1.89% | -2.64% | +33.47% | -2.04% | -39.43% | -16.45% | +10.28% | +35.43% | +14.71% | +18.24% |
| 2018 | +17.79% | -4.23% | +18.03% | +3.06% | +22.90% | +40.84% | -12.06% | +18.75% | +17% | -17.18% | -3.21% | -15.71% | +96.14% |
| 2017 | +13.23% | +0.16% | -4.86% | +22.50% | -17.70% | +12.97% | +14.45% | +4.43% | +12.58% | +8.71% | +12.90% | -0.05% | +102.84% |
Drawdown analysis of Sarepta Therapeutics (SRPT)
The maximum drawdown for the SRPT was -98.17%, occurring on Dec 18, 2008. Recovery took 2459 trading sessions.
The current SRPT drawdown is -90.58%.
Since Nov 1, 1999 SRPT has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 4 times
- 20% or more: 6 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.17% | Feb 9, 2000 | 2228 | Dec 18, 2008 | 2459 | Sep 26, 2018 | 4687 |
| -93.33% | Dec 22, 2020 | 1151 | Jul 25, 2025 | Ongoing | Ongoing | Ongoing |
| -54.92% | Sep 28, 2018 | 249 | Sep 26, 2019 | 182 | Jun 17, 2020 | 431 |
| -31.03% | Nov 8, 1999 | 24 | Dec 13, 1999 | 21 | Jan 12, 2000 | 45 |
| -27.14% | Jul 20, 2020 | 79 | Nov 9, 2020 | 28 | Dec 18, 2020 | 107 |
| -23.02% | Jan 27, 2000 | 2 | Jan 31, 2000 | 3 | Feb 3, 2000 | 5 |
| -6.62% | Jun 22, 2020 | 6 | Jun 30, 2020 | 13 | Jul 20, 2020 | 19 |
| -2.34% | Jan 13, 2000 | 1 | Jan 14, 2000 | 1 | Jan 18, 2000 | 2 |
| -0.73% | Nov 1, 1999 | 1 | Nov 2, 1999 | 1 | Nov 3, 1999 | 2 |